Product
CD34+ Bone Marrow Stem Cells
1 clinical trial
5 indications
Indication
Age-related Macular DegenerationIndication
Diabetic RetinopathyIndication
Retinal Vein OcclusionIndication
Retinitis PigmentosaIndication
Macular DegenerationClinical trial
A Pilot Clinical Trial of the Feasibility and Safety of Intravitreal Autologous Adult Bone Marrow Stem Cells in Treating Eyes With Vision Loss From RetinopathyStatus: Active (not recruiting), Estimated PCD: 2025-10-01